Improving Evidence Generation Through Point-Of-Care Trials
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Problems viewing this email?
Tuesday, August 23, 2022 | The Latest Research, Commentary, And News From Health Affairs
Dear John,

To mark the 25th anniversary of CHIP, we're hosting a virtual event for Health Affairs Insiders on August 30 to explore lessons learned over the past three decades about coverage expansion and future opportunities to sustain the program. Register today to join!
Drug Patents
In their article in the August issue, Victor Van de Wiele and coauthors review drug patents approved in 2019 and 2020.

The authors find that many patents covered aspects of a drug beyond its chemical compound, including its formulation and method of use.

Van de Wiele and coauthors report that the anticipated patent-protected market exclusivity period for the drugs they studied was a median of 10.3 years after drug approval, with the highest time difference between drug approval and latest expiration date being 20.3 years.

Their findings suggest that in the current market patent lengths are much more likely to be central considerations in drug manufacturers’ revenue predictions than other statutory exclusivities.

The authors conclude that patent reform is a critical step in ensuring timely generic entry of drug patents.
Advertisement
Elsewhere At Health Affairs
Today in Health Affairs Forefront, Caleigh Propes and coauthors discuss how a "point-of-care" approach to conducting clinical trials may bolster both the real-world value and external validity of clinical research data.

Katie Keith writes about a court ruling that greenlights non-ACA arrangements, and she indicates that if the Fifth Circuit ruling stands, it could undermine state insurance regulation.

If you like the work we publish on Forefront and our podcasts, you can show your support by becoming a Health Affairs Insider, and as an added bonus, you'll get a free gift for joining.
Ann Nguyen On Practicing Across State Lines In An Emergency

Ann Nguyen from Rutgers University joins A Health Podyssey to discuss what happens when you suspend interstate barriers to medical practice.

Daily Digest
 
Facebook
 
Twitter
 
Linkedin
 
Youtube
 
Email
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, update your email preferences here
.